Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Survivin S81A Enhanced TRAIL's Activity in Inducing Apoptosis

The Indonesian Biomedical Journal · Vol. 2 No. 3 (2010) · hlm. 113–113

DOI
10.18585/inabj.v2i3.124
ISSN
2085-3297, 2355-9179
Terbit
2010-12-01
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Survivin is rarely expressed in normal healthy adult tissues, however, it is upregulated in the majority of cancers. Survivin, which belongs to IAPs family, has been widely reported to protect cells from apoptosis by inhibiting caspases pathway. Survivin’s mitotic activity is modulated by many kinases, and its phosphor status can also influence its ability to inhibit apoptosis. There are several important survivin’s phosphorylation sites, such as S20 and T34. We have continued our investigation on other potential survivin’s phosphorylation sites that could be important site for regulating survivin’s cyto-protection.METHODS: By assuming that S81 could be a potential target to modify activity of survivin, wild-type survivin (Survivin), antisense survivin (Survivin-AS), mutated-survivin Thr34Ala (Survivin-T34A) and mutated-survivin Ser81Ala (Survivin-S81A) were constructed and inserted into pMSCV-IRES-GFP vector with cytomegalovirus (CMV) promoter. Each retroviral product was produced in BOSC23 cells. LY294002 pretreatment and TRAIL treatment along with infection of retroviral products were performed in murine fibrosarcoma L929 cells. For analysis, flow cytometric apoptosis assay and western blot were performed.RESULTS: In our present study, survivin for providing cytoprotection was regulated by PI3K. The results showed that LY294002, an inhibitor of PI3K, effectively suppressed survivin-modulated cytoprotection in a TRAIL-induced apoptotic model. In addition, mutated survivin S81A showed marked suppression on survivin’s cytoprotection. Along with that, TRAIL’s apoptotic activity was enhanced for inducing apoptosis.CONCLUSION: We suggested that survivin could inhibit apoptosis through PI3K and S81A could be another potential target in order to inhibit Survivin-modulated cytoprotection as well as to sensitize efficacy of TRAIL or other related apoptotic inducers.KEYWORDS: apoptosis, survivin, TRAIL, S81A, L929, LY294002

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 94 tautan kepenulisan bersama · 52 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Trisakti
  • University of Indonesia
  • University of Brawijaya
  • Universitas Airlangga
  • Hasanuddin University
  • PT Prodia StemCell Indonesia (Indonesia)
  • Kyushu University
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Muhammad Ihsan RizalUniversitas Trisakti5
Nurrani Mustika DewiPadjadjaran University5
Dewi RanggainiUniversitas Trisakti5
Melanie Sadono DjamilUniversitas Trisakti5
Janti SudionoUniversitas Trisakti4
Johni HalimUniversitas Trisakti4
Angliana ChouwPT Prodia StemCell Indonesia (Indonesia)4
Djanggan SargowoUniversity of Brawijaya4
Visi Endah PratitisAfiliasi tidak diketahui4
Wahyu WidowatiMaranatha Christian University3
Yanni DirgantaraPT Prodia StemCell Indonesia (Indonesia)3
Maria CelinnaAfiliasi tidak diketahui3
Toshio KukitaKyushu University3
Alifah Evi ScaniaUniversity of Indonesia3
Kyung Hoon LeeAfiliasi tidak diketahui3
Irawan YusufHasanuddin University3
Ketherin KetherinUniversitas Trisakti2
Tjandrawati MozefIndonesian Institute of Sciences2
Ardian RizalUniversity of Brawijaya2
Tadahiko IijimaKyushu University2
Sonar Soni PanigoroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Herqutanto HerqutantoUniversity of Indonesia2
Solachuddin Jauhari Arief IchwanUniversiti Brunei Darussalam2
Andon HestiantoroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Nyoman Suci WidyastitiDiponegoro University2
Pudji RahajuUniversity of Brawijaya2
Ahmad Dian WahyudionoUniversity of Brawijaya2
Reza Gunadi RanuhUniversitas Airlangga2
Alpha Fardah AthiyyahUniversitas Airlangga2
Andy DarmaUniversitas Airlangga2
Subijanto Marto SudarmoUniversitas Airlangga2
Bambang SutrisnaUniversity of Indonesia2
Mansyur ArifHasanuddin University2
Andi WijayaHasanuddin University2
Primariadewi RustamadjiUniversity of Indonesia2
Aria KekalihUniversity of Indonesia2
Maria Leny RaiyonUniversitas Trisakti2
Nadya Saputri HalimAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Survivin S81A Enhanced TRAIL's Activity in Inducing Apoptosis</dc:title><dc:creator>Ferry Sandra</dc:creator><dc:creator>Roya Khosravi‐Far</dc:creator><dc:subject>survivin</dc:subject><dc:subject>TRAIL</dc:subject><dc:subject>apoptosis</dc:subject><dc:subject>phosphorylation sites</dc:subject><dc:subject>phosphatidylinositol 3-kinase</dc:subject><dc:subject>caspase inhibition</dc:subject><dc:subject>IAP family</dc:subject><dc:subject>cytoprotection</dc:subject><dc:subject>fibrosarcoma</dc:subject><dc:subject>LY294002</dc:subject><dc:subject>TRAIL sensitization</dc:subject><dc:description xml:lang="en">BACKGROUND: Survivin is rarely expressed in normal healthy adult tissues, however, it is upregulated in the majority of cancers. Survivin, which belongs to IAPs family, has been widely reported to protect cells from apoptosis by inhibiting caspases pathway. Survivin’s mitotic activity is modulated by many kinases, and its phosphor status can also influence its ability to inhibit apoptosis. There are several important survivin’s phosphorylation sites, such as S20 and T34. We have continued our investigation on other potential survivin’s phosphorylation sites that could be important site for regulating survivin’s cyto-protection.METHODS: By assuming that S81 could be a potential target to modify activity of survivin, wild-type survivin (Survivin), antisense survivin (Survivin-AS), mutated-survivin Thr34Ala (Survivin-T34A) and mutated-survivin Ser81Ala (Survivin-S81A) were constructed and inserted into pMSCV-IRES-GFP vector with cytomegalovirus (CMV) promoter. Each retroviral product was produced in BOSC23 cells. LY294002 pretreatment and TRAIL treatment along with infection of retroviral products were performed in murine fibrosarcoma L929 cells. For analysis, flow cytometric apoptosis assay and western blot were performed.RESULTS: In our present study, survivin for providing cytoprotection was regulated by PI3K. The results showed that LY294002, an inhibitor of PI3K, effectively suppressed survivin-modulated cytoprotection in a TRAIL-induced apoptotic model. In addition, mutated survivin S81A showed marked suppression on survivin’s cytoprotection. Along with that, TRAIL’s apoptotic activity was enhanced for inducing apoptosis.CONCLUSION: We suggested that survivin could inhibit apoptosis through PI3K and S81A could be another potential target in order to inhibit Survivin-modulated cytoprotection as well as to sensitize efficacy of TRAIL or other related apoptotic inducers.KEYWORDS: apoptosis, survivin, TRAIL, S81A, L929, LY294002</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2010-12-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v2i3.124</dc:identifier><dc:identifier>10.18585/inabj.v2i3.124</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 2 No 3 (2010); 113-113</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/124/152</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>